about
Loop diuretics affect skeletal myoblast differentiation and exercise-induced muscle hypertrophy.Salt suppresses IFNγ inducible chemokines through the IFNγ-JAK1-STAT1 signaling pathway in proximal tubular cellsWNK4 is an Adipogenic Factor and Its Deletion Reduces Diet-Induced Obesity in Mice.Drug-Repositioning Screening for Keap1-Nrf2 Binding Inhibitors using Fluorescence Correlation SpectroscopyHigh-throughput chemical screening identifies AG-490 as a stimulator of aquaporin 2 membrane expression and urine concentrationWNK4 is the major WNK positively regulating NCC in the mouse kidneyKelch-Like Protein 2 Mediates Angiotensin II-With No Lysine 3 Signaling in the Regulation of Vascular Tonus.Characterization of the putative phosphorylation sites of the AQP2 C terminus and their role in AQP2 trafficking in LLC-PK1 cells.Wnt5a induces renal AQP2 expression by activating calcineurin signalling pathway.Impaired degradation of WNK by Akt and PKA phosphorylation of KLHL3.EGF Receptor Inhibition by Erlotinib Increases Aquaporin 2-Mediated Renal Water Reabsorption.KLHL3 Knockout Mice Reveal the Physiological Role of KLHL3 and the Pathophysiology of Pseudohypoaldosteronism Type II Caused by Mutant KLHL3.Basolateral targeting and microtubule-dependent transcytosis of the aquaporin-2 water channel.Phosphatidylinositol 3-kinase/Akt signaling pathway activates the WNK-OSR1/SPAK-NCC phosphorylation cascade in hyperinsulinemic db/db mice.Treatment with 17-allylamino-17-demethoxygeldanamycin ameliorated symptoms of Bartter syndrome type IV caused by mutated Bsnd in mice.Ezrin directly interacts with AQP2 and promotes its endocytosis.Calcineurin inhibitors block sodium-chloride cotransporter dephosphorylation in response to high potassium intake.Impaired degradation of medullary WNK4 in the kidneys of KLHL2 knockout mice.Impaired degradation of WNK1 and WNK4 kinases causes PHAII in mutant KLHL3 knock-in mice.Generation and analyses of R8L barttin knockin mouseClinical importance of potassium intake and molecular mechanism of potassium regulationTacrolimus ameliorates the phenotypes of type 4 Bartter syndrome model mice through activation of sodium-potassium-2 chloride cotransporter and sodium-chloride cotransporter
P50
Q33572473-B94C49DB-E7B9-4F00-BA7E-81B2125752E0Q33582779-D36CC10B-5625-4F15-894F-DEAA865E52EEQ33603592-D90407E0-EC0E-4921-95B5-00BBA1A0C628Q33822548-9E45FB73-9A43-4F07-A208-9557C3A61B49Q34295359-D4F4858D-4123-4A2F-A36F-3A460E4B093DQ34420520-5FF4FABE-E889-4C58-B692-0945BC3F3BF9Q36003108-15639CB2-8FEE-4EC5-AD81-3227329F20DFQ36174490-617EDC0B-7EAC-4572-8F48-9893583E7C80Q37465201-13F2254E-8F36-4B74-BBFA-222C5C693624Q40468576-E525111B-6678-41AA-AA8D-14938704BA71Q41645505-50EDB30D-45ED-475F-BC4C-731FF1464A45Q41728387-0FB0F386-7C22-4D1D-9D18-14735AA9BB96Q42053033-4543DFF7-812E-478D-90E2-EE9B5FE72717Q42135510-04D5D9A0-39B9-4E0A-B4B9-856FFED95A6AQ45230643-356C2871-6EAD-4F19-9B19-DAB43AC0875FQ47952810-D14FF1EA-EAFB-4CF3-9FC4-D60BB353F010Q50774958-D65C3FDE-6045-49B2-AB5A-FD9C8F53CDAAQ51054878-46D0DC7A-65E0-47D5-AC73-347B0831E618Q53051338-EE0E8055-4CAE-4DB8-8210-34DD8D6311CDQ56974878-1CF65B7D-5FBC-43B3-9B2C-31BFF48B42ABQ91978230-327BD258-E56C-420D-AC22-668A829214ADQ92294252-9116D1A3-8B87-4582-8185-2AC86431BDCA
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Naohiro Nomura
@ast
Naohiro Nomura
@en
Naohiro Nomura
@es
Naohiro Nomura
@nl
type
label
Naohiro Nomura
@ast
Naohiro Nomura
@en
Naohiro Nomura
@es
Naohiro Nomura
@nl
prefLabel
Naohiro Nomura
@ast
Naohiro Nomura
@en
Naohiro Nomura
@es
Naohiro Nomura
@nl
P106
P31
P496
0000-0002-6998-1922